Involvement of γ-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex

European Journal of Pharmacology

Volumn 341, Issue 1, 1998, Pages 45-56

  Yonezawa, Yuji ^a   Kuroki, Toshihide ^a   Kawahara, Takeshi ^a   Tashiro, Nobutada ^a   Uchimura, Hideyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b Laboratory of Neurochemistry   (Japan)

Author keywords

Dopamine; GABA ( aminobutyric acid); Medial prefrontal cortex; Microdialysis; NMDA (N methyl D aspartate); Phencyclidine

Indexed keywords

DIZOCILPINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NOMIFENSINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; GABAERGIC TRANSMISSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMALS; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MUSCIMOL; N-METHYLASPARTATE; NOMIFENSINE; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 0032472316     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01435-0     Document Type: Article

References (68)

1. Allen R.M., Young S.J. Phencyclidine-induced psychosis. Am. J. Psychiatry. 35:1978;1081.
2. Beauregard M., Ferron A. Dopamine modulates the inhibition induced by GABA in rat cerebral cortex: an iontophoretic study. Eur. J. Pharmacol. 205:1991;225.
3. Bernath S., Zigmond M.J. Dopamine may influence GABA release via three separate mechanisms. Brain Res. 476:1989;373.
4. Bourdelais A.J., Deutch A.Y. The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. Cereb. Cortex. 4:1994;69.
5. Bowers M.B., Hoffman F.J. Effects of diazepam on regional brain homovanillic acid following phencyclidine or Δ9-tetrahydrocannabinol. Biochem. Pharmacol. 38:1989;2385.
6. Bowers M.B., Morton J.B. Diazepam antagonizes effects on dopamine metabolism produced by PCP receptor agonists. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 16:1992;211.
7. B receptor site distribution in the rat central nervous system. Neuroscience. 20:1987;365.
8. Bunney B.G., Potkin S.G., Bunney W.E. Jr. New morphological and neuropathological findings in schizophrenia: a neurodevelopmental perspective. Clin. Neurosci. 3:1995;81.
9. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28:1989;653.
10. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1:1989;179.
11. Chapman C.D., Gazzara R.A., Howard S.G. Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats. Neuropharmacology. 29:1990;319.
12. Collinge G.L., Lester R.A.J. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40:1989;145.
13. Cotman C.W., Monaghan D.T., Ottersen O.P., Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 10:1987;273.
14. Cowan R.L., Wilson C.J., Emson P.C., Heizmann C.W. Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J. Comp. Neurol. 302:1990;197.
15. - channel complex. J. Neurosci. 8:1988;602.
16. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural Transm. 36:1992;61.
17. Deutch A.Y., Tam S.-Y., Freeman A.S., Bowers M.B. Jr., Roth R.H. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Eur. J. Pharmacol. 134:1987;257.
18. Deutsch S.I., Mastropaolo J., Schwartz B.L., Rosse R.B., Morihisa J.M. A 'glutamatergic hypothesis' of schizophrenia. Clin. Neuropharmacol. 12:1989;1.
19. Dolan R.J., Fletcher P., Frith C.D., Friston K.J., Frackowiak R.S.J., Grasby P.M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature. 378:1995;180.
20. 3H ]GABA release from cultured cortex neurons Eur. J. Pharmacol. 143:1987;287.
21. 3H -GABA from cultured mouse cerebral cortex interneurons J. Neurosci. 7:1987;2910.
22. Drew K.L., O'Connor W.T., Kehr J., Ungerstedt U. Characterization of gamma-aminobutyric acid and dopamine overflow following acute implantation of a microdialysis probe. Life Sci. 45:1989;1307.
23. Fairen, A., DeFelipe, J., Regidor, J., 1984. Nonpyramidal neurons. General account. In: Jones, E.G., Peters, A. (Eds.), Cerebral Cortex (1). Plenum, New York, p. 201.
24. Feenstra M.G.P., Van der Weij W., Botterblom M.H.A. Concentration dependent dual action of locally applied N-methyl-D-aspartate on extracellular dopamine in the rat prefrontal cortex in vivo. Neurosci. Lett. 201:1995;175.
25. Freeman A.S., Bunney B.S. The effects of phencyclidine (PCP) and the enantiomers of N-allylnormetazocine (SKF-10,047) on midbrain dopamine neuronal activity. Eur. J. Pharmacol. 104:1984;287.
26. Giros B., El Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383.
27. Grobin A.C., Deutch A.Y. Dopaminergic regulation of extracellular GABA levels in the prefrontal cortex of the rats. Soc. Neurosci. Abstr. 21(2):1995;1375.
28. Hernandez L., Auerbach S., Hoebel B.G. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis. Life Sci. 42:1988;1713.
29. Hondo H., Yonezawa Y., Nakahara T., Nakamura K., Hirano M., Uchimura H., Tashiro N. Effect of phencyclidine on dopamine release in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res. 633:1994;337.
30. Hondo H., Nakahara T., Nakamura K., Hirano M., Uchimura H., Tashiro N. The effect of phencyclidine on the basal and high potassium evoked extracellular GABA levels in the striatum of freely moving rats: an in vivo microdialysis study. Brain Res. 671:1995;54.
31. Houser, C.R., Vaughn, J.E., Hendry, S.H.C., Jones, E.G., Peters, A., 1984. GABA neurons in the cerebral cortex. In: Jones, E.G., Peters, A. (Eds.), Cerebral Cortex (2). Plenum, New York, p. 63.
32. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301.
33. Jay T.M., Thierry A.M., Wiklund L., Glowinski J. Excitatory amino acid pathway from the hippocampus to the prefrontal cortex: contribution of the AMPA receptors in the hippocampo-prefrontal cortex transmission. Eur. J. Neurosci. 4:1992;1285.
34. Jedema H.P., Moghaddam B. Characterization of excitatory amino acid modulation of dopamine release in the prefrontal cortex of conscious rats. J. Neurochem. 66:1996;1448.
35. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18:1993;75.
36. Kaneyuki H., Yokoo H., Tsuda A., Yoshida M., Mizuki Y., Yamada M., Tanaka M. Psychological stress increases dopamine turnover selectively in mesoprefrontal dopamine neurons of rats: reversal by diazepam. Brain Res. 557:1991;154.
37. Kita H., Kosaka T., Heizmann C.W. Parvalbumin-immunoreactive neurons in the rat neostriatum: a light and electron microscopic study. Brain Res. 536:1990;1.
38. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B. Jr., Charney D.S. Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans. Arch. Gen. Psychiatry. 51:1994;199.
39. Lillrank S.M., O'Connor W.T., Sarasaari P., Ungerstedt U. In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthetized rats. Acta Physiol. Scand. 150:1994;109.
40. Maurice T., Vignon J., Kamenka J.-M., Chicheportiche R. Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo. J. Neurochem. 56:1991;553.
41. Maddox V.H., Godefroi E.F., Parcell R.F. The synthesis of phencyclidine and other L-arylcyclohexylamines. J. Med. Chem. 7:1965;230.
42. 3H ]SKF-10,047 to σ sites Eur. J. Pharmacol. 180:1990;361.
43. McCullough L.D., Salamone J.D. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res. 577:1992;1.
44. Moghaddam B., Roth R.H., Bunney B.S. Characterization of dopamine release in the rat medial frontal cortex as assessed by in vivo microdialysis: comparison to the striatum. Neuroscience. 36:1990;669.
45. Morrow B.A., Clark W.A., Roth R.H. Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist. Eur. J. Pharmacol. 238:1993;255.
46. Murphy B.L., Arnsten A.F.T., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. USA. 93:1996;1325.
47. Nishijima K., Kashiwa A., Nishikawa T. Preferential stimulation of extracellular dopamine in rat frontal cortex to striatum following competitive inhibition of the N-methyl-D-aspartate receptor. J. Neurochem. 63:1994;375.
48. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A., Nishikawa T. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse. 22:1996;304.
49. Paxinos, G., Watson, C., 1982. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
50. Penit-Soria J., Audinat E., Crepel F. Excitation of rat prefrontal cortical neurons by dopamine; an in vitro electrophysiological study. Brain Res. 425:1987;363.
51. Pirot S., Godbout R., Mantz J., Tassin J.-P., Glowinski J., Thierry A.-M. Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience. 49:1992;857.
52. Rao T.S., Kim H.S., Lehmann J., Martin L.L., Wood P.L. Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo. Life Sci. 45:1989;1065.
53. 3H ] GABA on rat prefrontal cortex slices Neuroscience. 42:1991;61.
54. Rétaux S., Caboche J., Rogard M., Julien J.F., Penit-Soria J., Besson M.J. GABA interneurons in the rat medial frontal cortex: characterization by quantitative in situ hybridization of the glutamic acid decarboxylase (GAD67) mRNA. Brain Res. 611:1993;187.
55. Santiago M., Machado A., Cano J. Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists. Eur. J. Pharmacol. 239:1993;83.
56. B receptor agonists and antagonists. Brain Res. 630:1993;28.
57. 2A receptor blockade. J. Pharmacol. Exp. Ther. 277:1996;1541.
58. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 290:1989;213.
59. Sesack S.R., Bressler C.N., Lewis D.A. Ultrastructural associations between dopamine terminals and local circuit neurons in the monkey prefrontal cortex: a study of calretinin-immunoreactive cells. Neurosci. Lett. 200:1995;9.
60. Smith A.D., Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci. 13:1990;259.
61. Thierry A.-M., Stinus L., Glowinski J. Dopaminergic terminals in rat cortex. Science. 182:1973;499.
62. Van Eden C.G., Hoorneman E.M.D., Buijs R.M., Matthijssen M.A.H., Geffard M., Uylings H.B.M. Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical levels. Neuroscience. 22:1987;849.
63. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660.
64. Westerink B.H.C., De Vries J.B. On the origin of extracellular GABA collected by brain microdialysis and assayed by a simplified on line method. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;603.
65. 3H ]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes J. Neurochem. 50:1988;274.
66. 2 receptor. Eur. J. Pharmacol. 285:1995;305.
67. Zhang J., Chiodo L.A., Freeman A.S. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res. 590:1992;153.
68. Zhang J., Chiodo L.A., Freeman A.S. Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons. Eur. J. Pharmacol. 230:1993;371.